Chemoenzymatic Synthesis of Glycopeptides with PglB, a Bacterial Oligosaccharyl Transferase from Campylobacter jejuni  by Glover, Kerney Jebrell et al.
Chemistry & Biology, Vol. 12, 1311–1316, December, 2005, ª2005 Elsevier Ltd All rights reserved. DOI 10.1016/j.chembiol.2005.10.004Chemoenzymatic Synthesis of Glycopeptides
with PglB, a Bacterial Oligosaccharyl Transferase
from Campylobacter jejuniKerney Jebrell Glover,1,3,4 Eranthie Weerapana,1,3,4
Shin Numao,2 and Barbara Imperiali1,3,*
1Departments of Chemistry and Biology
Massachusetts Institute of Technology
77 Massachusetts Avenue
Cambridge, Massachusetts 02139
2 Institute of Microbiology
Department of Biology
Swiss Federal Institute of Technology
CH-8092, Zu¨rich
Switzerland
Summary
The gram-negative bacterium Campylobacter jejuni
has a generalN-linked glycosylation pathway encoded
by thepgl gene cluster. One of the proteins in this clus-
ter, PglB, is thought to be the oligosaccharyl transfer-
ase due to its significant homology to Stt3p, a subunit
of the yeast oligosaccharyl transferase complex. PglB
has been shown to be involved in catalyzing the
transfer of an undecaprenyl-linked heptasaccharide
to the asparagine side chain of proteins at the Asn-
X-Ser/Thr motif. Using a synthetic disaccharide gly-
can donor (GalNAc-a1,3-bacillosamine-pyrophosphate-
undecaprenyl) and a peptide acceptor substrate (KD
FNVSKA), we can observe the oligosaccharyl transfer-
ase activity of PglB in vitro. Furthermore, the prepara-
tion of additional undecaprenyl-linked glycan variants
reveals the ability of PglB to transfer a wide variety
of saccharides. With the demonstration of PglB activ-
ity in vitro, fundamental questions surrounding the
mechanism of N-linked glycosylation can now be ad-
dressed.
Introduction
Recent studies have revealed the presence of N-linked
glycoproteins in the gram-negative bacterium Campylo-
bacter jejuni, which is involved in human gastroenteric
disorders [1]. Evidence suggests that theseN-linked gly-
cans play a major role in host adherence, invasion, and
colonization [2]. Similar to the corresponding process
in eukaryotes, the glycan is attached to the asparagine
side chain at the Asn-X-Ser/Thr motif where X can be
any amino acid except proline [3]. In C. jejuni, the glycan
that is transferred is the heptasaccharide GalNAc-
a1,4-GalNAc-a1,4-(Glcb1,3)-GalNAc-a1,4-GalNAc-a1,
4-GalNAc-a1,3-Bac, where Bac is bacillosamine (2,4-
diacetamido-2,4,6-trideoxyglucose) [4]. Genetic studies
have identified a locus (dubbed pgl for protein glycosyl-
ation) that is responsible for this process. This locus can
be functionally reconstituted inEscherichia coli, strongly
suggesting that it contains all the genes necessary for
*Correspondence: imper@mit.edu
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4 These authors contributed equally to this work.the N-linked glycosylation process [5]. Three major
classes of proteins are represented in the pgl gene clus-
ter: carbohydrate-modifying enzymes responsible for the
biosynthesis of the bacillosamine, glycosyltransferases
that assemble the prenyl-linked heptasaccharide, and
most importantly the oligosaccharyl transferase (PglB),
which is responsible for transferring the preassembled
heptasaccharide to protein [6].
The current model for the pgl pathway (Figure 1) is
based on bioinformatic, biochemical, and mutational
analyses, and shares some features with the dolichol
pathway in yeast and the O-antigen pathway in bacteria
[6, 7]. The pathway begins on the cytoplasmic side of the
periplasmic membrane with a UDP-HexNAc (either
GlcNAc or GalNAc), which is converted to UDP-Bac.
UDP-Bac is then linked to undecaprenyl-phosphate
through the action of PglC to create the first membrane-
anchored intermediate undecaprenyl-pyrophosphate-
linked bacillosamine (Und-PP-Bac). This product is then
elaborated by PglA, J, H, and I to produce the heptasac-
charide, which is then flipped by WlaB into the periplasm.
Once in the periplasm, PglB transfers the completed
heptasaccharide, affording a b-linked glycan to the as-
paragine side chain of target proteins.
PglB is an 82 kDa integral membrane protein that re-
sides in the periplasmic membrane. It comprises two
domains, a hydrophobic domain containing approxi-
mately 10–12 membrane-spanning segments and a
smaller soluble domain (TMHMM, ExPASY). Interest-
ingly, PglB shares significant homology to Stt3p, a sub-
unit of the nine-membered yeast oligosaccharyl transfer-
ase (OT) complex. Importantly, PglB and Stt3p along
with other similar homologs have a conserved signature
sequence of WWDYGY, which has been shown to be es-
sential for activity in vivo [5].
In this study, we have prepared a membrane fraction
from E. coli in which PglB has been overexpressed. Us-
ing a synthetic undecaprenyl-linked glycan (GalNAc-a1,
3-bacillosamine-pyrophosphate-undecaprenyl, GalNAc-
Bac-PP-Und) [8], we have been able to observe the
transfer of the disaccharide to the peptide acceptor
(KDFNVSK). Further studies have revealed that PglB also
accepts the disaccharides GalNAc-GlcNAc-PP-Und and
GalNAc-6-hydroxybacillosamine-PP-Und. Studies also
reveal that an octapeptide based upon sequences from
known glycoproteins in C. jejuni is favored over a simple
N- and C-terminal capped NLT tripeptide, revealing that
there are additional amino acid determinants that pro-
vide optimal OT activity in the C. jejuni enzyme.
Results and Discussion
Substrates for N-Linked Glycosylation In Vitro
In order to define an optimal peptide substrate, se-
quence alignments were done against two known peri-
plasmic proteins, PEB3 and AcrA, which have been
established to be glycosylated inC. jejuni. AcrA is glyco-
sylated at Asn123, while PEB3 is glycosylated at Asn90
[9, 10]. When those regions are aligned, the first three
amino acids preceding the Asn are strictly conserved.
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Figure 2. Design of Peptide Substrates and Overview of PglA and PglB Reactions
(A) Sequence alignment of residues flanking the glycosylation sites of PEB3 and AcrA and the resulting consensus peptide.
(B) Synthesis of radiolabeled undecaprenyl-linked disaccharide using PglA, synthetic undecaprenyl-pyrophosphate bacillosamine, and triti-
ated UDP-GalNAc. Bold highlights the position of the tritium label.
(C) Overview of the desired PglB reaction using prenyl-linked saccharide highlighted in (B) and the consensus peptide shown in (A).
W W D Y G Y
W A A Y G Y
Wild Type
Mutant
A
B
C
1 2
0
500
1000
1500
2000
0 2 4 6 8 10
D
PM
Time (min)
Figure 3. In Vitro Activity of Wild-Type and Mutant PglB
(A) Sequence alignment of the highly conserved OT hexa-amino
acid motif. The PglB mutant has two alanine substitutions within
this motif.
(B) Anti-T7 tag Western blot of bacterial membranes overexpressing
PglB and the mutant counterpart. Lane 1, wild-type; lane 2, mutant.
(C) Plot of glycopeptide product formation as a function of time. Solid
line, wild-type; dashed line, mutant. This plot is a representation of
product formation and should not be interpreted as kinetic data.However, the residue after the Asn appears to be vari-
able. The next two residues, Ser and Lys, are also highly
conserved in these two proteins. In order to create the
consensus sequence for glycosylation, all conserved
residues were retained to create the KDFNVSKA octa-
peptide sequence, which was prepared with a free N ter-
minus and a C-terminal amide (Figure 2A).
The prenyl-linked sugar substrate was obtained che-
moenzymatically, using the glycosyltransferase PglA,
which adds a GalNAc to Und-PP-Bac in high yield.
PglA also accepts Und-PP-GlcNAc and Und-PP-6-hydroxybacillosamine to a lesser extent. Und-PP-Bac
is obtained via chemical synthesis [8] and radiolabeled
disaccharide substrate can be readily prepared by using
UDP-3H-GalNAc as the substrate for the PglA reaction
(Figure 2B). The disaccharide was selected as the mini-
mal glycan donor for PglB based upon precedent from
the eukaryotic oligosaccharyl transferases, which read-
ily accept a truncated disaccharide substrate in vitro
[11, 12]. If the PglB reaction proceeds as anticipated,
a glycosylated peptide containing the tritiated disaccha-
ride will be formed (Figure 2C).
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Figure 4. Reverse-Phase HPLC Traces of
Peptide and Glycopeptide Products
These experiments were performed with the
more synthetically accessible 6-hydroxyba-
cillosamine derivative.
(A) HPLC trace of peptide after PglB wild-
type reaction.
(B) MALDI-MS of glycopeptide product.
(C) Radioactive HPLC trace of wild-type
PglB reaction.
(D) HPLC trace of peptide after PglB mutant
reaction.
(E) MALDI-MS of unglycosylated peptide
product.
(F) Radioactive HPLC trace of mutant PglB
reaction.Preparation of PglB
Two PglB constructs were prepared. The native 82 kDa
PglB protein was cloned into a vector such that the final
construct was a T7$Tag-PglB-(His)6 (T7$Tag is for anti-
body recognition). In addition, because the bacterial,
fungal, and yeast OTs all contain a highly conserved,
6-residue signature sequence WWDYGY (Figure 3A),
a second homologous construct, in which two of these
residues were mutated, was also prepared. According
to the work of Aebi and coworkers, if the WWDYGY sig-
nature sequence is mutated to WAAYGY, PglB is no lon-
ger active in vivo [5]. Both proteins were overexpressed
in E. coli and a bacterial membrane preparation of each
was used for activity assays. The anti-T7 Western blot
shown in Figure 3B confirms that both the wild-type
and mutant are expressed in E. coli. Next, both the mu-
tant and wild-type PglB were assayed for oligosaccharyl
transferase activity. The assay used was one that was
already established for assaying yeast microsomes for
OT activity [11, 13]. Briefly, PglB is added to a solution
containing the peptide and glycan substrates for PglB.
An aqueous/organic phase separation partitions the
peptide into the aqueous phase, while the tritiated poly-
prenol-linked saccharide starting material remains in the
organic phase. If oligosaccharyl transferase activity isobserved, there will be a net transfer of radioactivity
from the organic phase into the aqueous phase. The re-
sults from this assay are shown in Figure 3C. This assay
clearly shows that the wild-type PglB readily transfers
radioactive carbohydrate to an aqueous soluble frac-
tion, whereas the mutant shows no comparable activity.
Furthermore, the negligible slope of the mutant curve
confirms that there is negligible hydrolysis of the Und-
PP-Bac pyrophosphate within the time frame of the
experiment.
In order to further confirm the presence of glycopep-
tide, the peptide products of overnight reactions were
subjected to HPLC analysis. With wild-type PglB, the
peptide product elutes from the reverse-phase column
at TR = 17.5 min (Figure 4A), while the peptide product
from a similar incubation using the mutant PglB elutes
at TR = 18.0 min (Figure 4D). When these peaks are col-
lected and subjected to mass spectral analysis, a mass
corresponding to the glycopeptide is observed for the
wild-type (Figure 4B), while the mutant is that of the un-
glycosylated peptide (Figure 4E). The presence of a sin-
gle peak in both mass spectra shows that the glycopep-
tide product is not modified by host transferases or
proteases. Interestingly, the presence of only a single
product in the mass spectrum coupled with the3H-GalNAc- 1,3-Bac-PP-Und 3H-GalNAc- 1,3-6-hydroxybac-PP-Und 3H-GalNAc- 1,3-GlcNAc-PP-Und
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Figure 5. Specificity of PglB for Undecap-
renyl-Pyrophosphate-Linked Disaccharides
(3H-GalNAc-X-PP-Und)
This plot is a representation of product for-
mation; it is not a representation of kinetic
analysis, and strong conclusions about ac-
ceptance rates should not be made. Solid
line, X, bacillosamine; dashed line, X, GlcNAc;
dotted line, X, 6-hydroxybacillosamine.
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Figure 6. Utilization of Various Undecaprenyl-Pyrophosphate-
Linked Saccharide Intermediates
The more readily available 6-hydroxybacillosamine substrate was
used for this study in place of the native bacillosamine. The variation
in the levels of DPM incorporation reflects the different amounts of
lipid-linked sugar substrate in each reaction; therefore, conclusions
about the relative reaction rates cannot be made.
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Figure 7. Peptide Substrate Specificity of
PglB
(A) Radioactive assay of product formation.
Solid line, octapeptide consensus sequence
(KDFNVSKA); dashed line, tripeptide consen-
sus for yeast OT (Bz-NLT-NHMe). 6-hydroxy-
bacillosamine was used in this study in place
of the native bacillosamine substrate. The plot
is not a representation of kinetic parameters.
(B) HPLC trace of Bz-NLT-NHMe reaction.
(C) MALDI-MS of Bz-NLT-NHMe glycopep-
tide (peak at TR = 27.0 min).appearance of a single HPLC peak suggests that there is
complete conversion to glycopeptide. Furthermore, if
radiolabeled glycan substrate is used, a strong radioac-
tive peak at a similar retention time as the glycopeptide
(Figure 4C) confirms that the radioactivity in the aqueous
layer is a result of radiolabeled glycopeptide and not
a hydrolysis product, which elutes very early (TR = 4
min) from the reverse-phase column (Figure 4C, arrow).
In addition, the assay including the mutant PglB does
not show a radioactive peak (Figure 4F), further confirm-
ing that it is deficient in transferase activity.
Utilization of Diverse Polyprenolpyrophosphate-
Linked Glycans by PglB
Three disaccharide substrates were prepared using
a chemoenzymatic approach. As presented previously,
synthetic Und-PP-bacillosamine, Und-PP-6-hydroxy-
bacillosamine, and Und-PP-GlcNAc were reacted with
PglA and UDP-GalNAc to form the corresponding radio-labeled disaccharides [14]. These polyisoprene-linked
disaccharides were then assayed with PglB to deter-
mine the specificity of PglB for the saccharide proximal
to the pyrophosphate moiety. The results from this
assay are shown in Figure 5. It appears that PglB will ac-
cept the unnatural 6-hydroxybacillosamine and GlcNAc
analogs, although the bacillosamine substrate appears
to be the most efficient of the three. These data agree
with in vivo studies which have shown that PglB can
transfer several structurally different O-antigen saccha-
rides to protein [15].
The native substrate for PglB is a heptasaccharide,
but we have shown that PglB readily accepts a disaccha-
ride in vitro. Mutagenesis studies of proteins in the Pgl
pathway have resulted in the transfer of truncated sac-
charides to protein, strongly suggesting that PglB has
low specificity for the substrate length when functionally
reconstituted in E. coli [10]. In vitro, we can access trun-
cated substrates using various combinations of glyco-
syltransferases in the pgl pathway. With PglA, we can
access the disaccharide (GalNAc-Bac), with PglA and
J, we form the trisaccharide (GalNAc2-Bac), with PglA,
J, and H, we form the hexasaccharide (GalNAc5-Bac),
and finally, with PglA, J, H, and I, we form the heptasac-
charide (GalNAc2[Glc]GalNAc3-Bac) [14]. Studies with
these intermediate sugars in vitro demonstrate that
PglB readily accepts these substrates (Figure 6), further
reinforcing the observations made by Linton et al. [10] in
the in vivo system.Peptide Specificity of PglB
Next, the oligosaccharyl transferase activity of PglB on
the octapeptide was compared with the known tripep-
tide acceptor (Bz-NLT-NHMe) for the yeast OT system
[12, 13]. Clearly, Bz-NLT-NHMe is a poor acceptor for
the bacterial system (Figure 7A). The Bz-NLT NHMe pep-
tide was subjected to HPLC analysis similar to the con-
sensus peptide discussed above. The HPLC trace (Fig-
ure 7B) shows the presence of two peaks which were
confirmed by mass spectral analysis to be the glycopep-
tide (TR = 27.0 min; Figure 7C) and its unglycosylated
counterpart (TR = 29.0 min; data not shown). The pres-
ence of a significant amount of unglycosylated peptide
when subjected to the exact reaction conditions as the
consensus peptide together with the low rate of transfer
observed in Figure 7A strongly suggests that PglB has
additional determinants for the peptide substrate be-
yond the minimal tripeptide consensus sequence that
is well recognized in eukaryotes [3]. Further studies into
the peptide specificity of PglB are currently in progress.
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The experiments described here demonstrate the
in vitro oligosaccharyl transferase activity of PglB.
By using a combination of chemical synthesis and en-
zymology, we were able to prepare various glycan and
peptide substrates for this remarkable enzyme. The re-
sults demonstrate that PglB has a relaxed substrate
specificity accepting peptide substrates in place of
full-length proteins, making it potentially useful for the
preparation of artificial glycopeptides. Furthermore,
the observation that PglB can transfer undecaprenyl-
pyrophosphate-linked saccharides of various lengths
(two to seven saccharides) adds to the promise of
using PglB in the synthesis of diverse glycopeptide
products. However, PglB does require determinants
in the peptide sequence beyond the canonical N-X-S/T
tripeptide and with this in vitro assay in place, further
studies to determine the role of the amino acid binding
determinants can be readily undertaken. Although the
experiments described in this work strongly suggest
that PglB is solely responsible for oligosaccharyl
transferase activity, the presence of an accessory pro-
tein(s) in E. coli cannot be ruled out due to the use of a
bacterial membrane fraction. Currently, work is under-
way to purify PglB to homogeneity, which will unam-
biguously demonstrate whether it alone is responsible
for the oligosaccharyl transferase activity. Further-
more, detailed investigations into the poorly under-
stood mechanism of oligosaccharyl transferases are
more feasible using PglB as opposed to the multisub-
unit eukaryotic complexes. Last, the development of
powerful inhibitors of this enzyme would be valuable
in the quest for antibiotics forC. jejuni-induced gastro-
intestinal disorders.
Experimental Procedures
Expression of PglB
Starting from a 5 ml overnight culture, E. coli strains expressing PglB
were grown at 37ºC in LB broth to an OD600 of 0.6–0.8. At that point,
the temperature was reduced to 16ºC and protein production was
induced by the addition of isopropyl-b-D-thiogalactopyranoside
(1 mM). After 24 hr, the cells were harvested by centrifugation
(50003g) for 30 min, washed once with 0.9% NaCl solution, recentri-
fuged (5000 3 g) for 30 min, and frozen at 280ºC until needed.
Preparation of PglB Membrane Fraction
All steps were performed at 4ºC. The E. coli cell pellets expressing
PglB (wild-type and mutant) were thawed and resuspended in 5%
of the original culture volume in buffer M (50 mM Tris-acetate [pH
8.0], 1 mM EDTA). The cells were then subjected to sonication (3 3
15 s), unbroken cells were removed by centrifugation at 5,697 3 g
for 15 min, and the membrane fraction was collected by centrifuga-
tion at 142,414 3 g for 60 min. The pellet was washed once with
buffer M, centrifuged again, and resuspended in 0.25% of the orig-
inal culture volume in buffer M. The final suspension was aliquoted
and stored at 280ºC.
Preparation of Prenyl-Linked Disaccharides Using PglA
To a tube containing 0.06 mg of dried Und-PP-Bac, Und-PP-6-
hydroxybacillosamine, or Und-PP-GlcNAc, 3 ml of DMSO and 7 ml
of 14.3% (v/v) Triton X-100 were added. After vortexing and sonica-
tion (water bath), 58 ml of water, 4 ml of 1 M Tris-acetate (pH 8.5), 1 ml
of 1 M MgCl2, and 20 ml of PglA (660 mg/ml) were added. The reaction
was initiated by the addition of 7.5 ml of UDP-GalNAc (55 nCi/nmol).
After 120 min, the reaction was quenched in 1.6 ml of 2:1 chloro-
form:methanol and extracted three times with 320 ml of pure solventupper phase (15 ml chloroform:240 ml methanol:235 ml water:1.83 g
KCl). The organic layer was aliquoted and dried under a stream of ni-
trogen (w20,000–30,000 disintegrations per minute [DPM]/tube).
Peptide Synthesis
Peptides were synthesized by automated peptide synthesis (ABI
431A peptide synthesizer; Applied Biosystems, Foster City, CA) us-
ing standard Fmoc peptide synthesis conditions on PAL-PEG-PSf
resin. The resulting peptides were cleaved from the resin using tri-
fluoroacetic acid and purified by preparative reverse-phase high-
pressure liquid chromatography using a standard acetonitrile/water
gradient.
PglB Assay
To a tube of the labeled disaccharide, 10 ml of DMSO, 100 ml of 23
assay buffer (100 mM HEPES [pH 7.5], 280 mM sucrose, 2.4% [v/v]
Triton-X-100), 2 ml of 1 M MnCl2, and 28 ml of water was added. Re-
actions were initiated by the addition of 10 ml of a 2 mM stock of the
peptide in DMSO. Forty microliters of the reaction mixture was re-
moved at various time points and quenched into 1 ml of 3:2 chloro-
form:methanol + 200 ml of 4 mM MgCl2. The aqueous layer was ex-
tracted and the organic layer was washed twice with 600 ml of
pure solvent upper phase. The aqueous layers were combined,
mixed with 5 ml of scintillation fluid (EcoLite; MP Biomedicals, Irvine,
CA), and subjected to scintillation counting (2 min per tube).
HPLC Analysis of Glycopeptides
A 40 ml reaction aliquot was quenched as above and the aqueous
layer was dried under vacuum. The residue was resuspended in
50 ml of water and injected on a reverse-phase C18 column and
eluted under a standard water/acetonitrile gradient. Fractions
were collected every minute, mixed with scintillation fluid (EcoLite;
MP Biomedicals), and subjected to scintillation counting (2 min
per tube).
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